Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 244-017-3 | CAS number: 20769-85-1
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 999
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Qualifier:
- according to guideline
- Guideline:
- other: ICH tripartite harmonised guideline on genotoxicity : specific aspects of regulatory tests
- Qualifier:
- according to guideline
- Guideline:
- other: Japonese MHW
- Qualifier:
- according to guideline
- Guideline:
- other: EPA OPPTS-42193 Mammalian Erythrocyte Micronucleus Test
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- 2-bromo-2-methylpropionyl bromide
- EC Number:
- 244-017-3
- EC Name:
- 2-bromo-2-methylpropionyl bromide
- Cas Number:
- 20769-85-1
- Molecular formula:
- C4H6Br2O
- IUPAC Name:
- 2-bromo-2-methylpropanoyl bromide
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- CD-1
- Sex:
- male/female
Administration / exposure
- Route of administration:
- intraperitoneal
- Vehicle:
- Corn oil
- Duration of treatment / exposure:
- Once daily
- Frequency of treatment:
- Two consecutive days
- Post exposure period:
- 2 days
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
300, 400, 500, 1000, 1500, 1750, 2000 mg/kg
Basis:
nominal conc.
Range-finder experiment
- Remarks:
- Doses / Concentrations:
75, 150, 300
Basis:
nominal conc.
Main study experiment
- No. of animals per sex per dose:
- 3 males / 3 females per dose : range-finder experiment
8 males per dose : main study - Control animals:
- yes
- Positive control(s):
- Cyclophosphamide (CPA) used as positive control
Examinations
- Tissues and cell types examined:
- Polychromatic / normochromatic erythrocytes
Results and discussion
Test results
- Sex:
- male
- Genotoxicity:
- positive
- Toxicity:
- yes
- Remarks:
- up to 300 mg/kg
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): positive
It is concluded that 2-bromoisobutyryl bromide induced micronuclei in the polychromatic erythrocytes of the bone marrow of mice treated up to 300 mg/kg/day, a dose at which clinical signs and evidence of bone marrow toxicity was seen.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
